Ładuje się......
Diabetic cardiomyopathy: prevalence, determinants and potential treatments
The prevalence of type 2 diabetes (T2D) has reached a pandemic scale. These patients are at a substantially elevated risk of developing cardiovascular disease, with heart failure (HF) being a leading cause of morbidity and mortality. Even in the absence of traditional risk factors, diabetes still co...
Zapisane w:
| Wydane w: | Ther Adv Endocrinol Metab |
|---|---|
| Główni autorzy: | , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
SAGE Publications
2019
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6437329/ https://ncbi.nlm.nih.gov/pubmed/30944723 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2042018819834869 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|